On Nov. 27, the FDA published the FDA Voices: “FDA Protects Patients from Harmful Drugs Through the Drug Supply Chain Security Act,” by Jaqueline Corrigan-Curay, Office of the Center Director, Center for Drug Evaluation and Research (CDER) and Jill Furman, Office of Compliance, CDER.
Since 2013, the FDA has been implementing the Drug Supply Chain Security Act, a law known as DSCSA. This law gives the FDA more regulatory tools to detect and help ensure the removal of dangerous drugs from the supply chain, such as those that may be counterfeit, stolen, contaminated, or otherwise harmful. By fully implementing DSCSA, together with industry and other stakeholders, we will create a more secure pharmaceutical supply chain that will assure the continued distribution of safe prescription drugs for the benefit of public health.
FDA has the article.
